<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2018-18-56-61</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-2794</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ТЕРАПИЯ БОЛИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PAIN THERAPY</subject></subj-group></article-categories><title-group><article-title>Нестероидные противовоспалительные препараты в терапевтической практике: в фокусе – нимесулид</article-title><trans-title-group xml:lang="en"><trans-title>Nonsteroidal anti-inflammatory drugs in therapeutic practice: nimesulide in focus</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кетова</surname><given-names>Г. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Ketova</surname><given-names>G. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кетова Галина Григорьевна – доктор медицинских наук, профессор кафедры поликлинической терапии и клинической фармакологии.</p><p>Челябинск</p></bio><bio xml:lang="en"><p>Chelyabinsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Барышева</surname><given-names>В. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Barysheva</surname><given-names>V. O.</given-names></name></name-alternatives><bio xml:lang="en"><p>Chelyabinsk</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Южно-Уральский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>South Ural State Medical University of the Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Барышева Валерия Олеговна – кандидат медицинских наук, ассистент кафедры поликлинической терапии и клинической фармакологии.&#13;
Челябинск</institution><country>Россия</country></aff><aff xml:lang="en"><institution>South Ural State Medical University of the Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>17</day><month>11</month><year>2018</year></pub-date><volume>0</volume><issue>18</issue><fpage>56</fpage><lpage>61</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кетова Г.Г., Барышева В.О., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Кетова Г.Г., Барышева В.О.</copyright-holder><copyright-holder xml:lang="en">Ketova G.G., Barysheva V.O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/2794">https://www.med-sovet.pro/jour/article/view/2794</self-uri><abstract><p>В статье представлены данные проведенного анкетирования врачей Челябинска по вопросам применения нестероидных противовоспалительных препаратов. Обсуждены основные показания к их применению. Рассмотрены ключевые вопросы выбора лекарственных препаратов из группы НПВП с учетом эффективности, безопасности и области применения. Представлены данные последних научных исследований, проведенных в России и за рубежом, по вопросам эффективности, безопасности, эпидемиологии применения НПВП и парацетамола.</p></abstract><trans-abstract xml:lang="en"><p>The article presents the findings of questionnaire-based survey on the use of non-steroidal anti-inflammatory drugs conducted by the Chelyabinsk practitioners. It discusses the main indications for use of NSAIDs. The authors outline the key issues of the choice of drugs from the NSAID group, taking into account efficacy, safety and area of intended use. They also present the findings of the latest research studies conducted in Russia and abroad on the issues of efficacy, safety, epidemiology of the use of NSAIDs and paracetamol.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>болевой синдром</kwd><kwd>нестероидные противовоспалительные препараты (НПВП)</kwd><kwd>нимесулид</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pain syndrome</kwd><kwd>nonsteroidal anti-inflammatory drugs (NSAIDs)</kwd><kwd>nimesulide</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Жураховская Д.В., Лоскутова Е.Е., Виноградова И.А. Маркетинговый анализ фармацевтического рынка нестероидных противовоспалительных препаратов на региональном уровне. Современные проблемы науки и образования, 2014, 2: (электронный доступ: https://scienceeducation.ru/ru/article/view?id=12853, 16.09.18).</mixed-citation><mixed-citation xml:lang="en">Zhurakhovskaya DV, Loskutova EE, Vinogradova IA. Marketing analysis of the pharmaceutical non-steroidal anti-inflammatory drug market at the regional level. Sovremennye Problemy Nauki i Obrazovaniya, 2014, 2: (electronic access: https:// science-education.ru/ru/article/view?id=12853, 16.09.18).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Шварц Г.Я. Фармакогенетические особенности метаболизма современных НПВП и риск гастротоксических осложнений. Лекарственные средства: прикладная фармакология и персонализированная фармакотерапия, 2010, 1(1): 65-70.</mixed-citation><mixed-citation xml:lang="en">Schwartz GYa. Pharmacogenetic features of the metabolism of modern NSAIDs and the risk of gastrotoxic complications. Lekarstvennye Sredstva: Prikladnaya Farmakologiya i Personalizirovannaya Farmakoterapiya, 2010, 1 (1): 65-70.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Каратеев А.Е., Барскова В.Г. Безопасность нимесулида: эмоции или взвешанная оценка? Consilium medicum, 2007, 9: 60-64.</mixed-citation><mixed-citation xml:lang="en">Karateev AE, Barskova VG. Safety of nimesulide: emotions or weighted estimate? Consilium Medicum, 2007, 9: 60-64.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Насонов Е.Л. Эффективность и переносимость нестероидного противовоспалительного препарата. Нимесулид: новые данные. РМЖ, 2001,15: 6-8.</mixed-citation><mixed-citation xml:lang="en">Nasonov EL. Efficacy and tolerability of nonsteroidal anti-inflammatory drugs. Nimesulide: new data. RMJ, 2001,15: 6-8.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Олюнин Ю.А., Никишина Н.Ю. Возможности использования НПВП в клинической практике: фокус на нимесулид. Медицинский Совет, 2017, 17: 124-131.</mixed-citation><mixed-citation xml:lang="en">Olyunin YuA, Nikishina NYu. Possibilities of using NSAIDs in clinical practice: focus on nimesulide. Meditsinsky Sovet, 2017, 17: 124-131.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Rainsford K. Nimesulide -- a multifactorial approach to inflammation and pain: scientific and clinical consensus. Curr Med Res Opin, 2006, 22(6): 1161-70.</mixed-citation><mixed-citation xml:lang="en">Rainsford K. Nimesulide -- a multifactorial approach to inflammation and pain: scientific and clinical consensus. Curr Med Res Opin, 2006, 22(6): 1161-70.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Rainsford K. Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide. Inflammopharmacology, 2006, 14(3-4): 120-37.</mixed-citation><mixed-citation xml:lang="en">Rainsford K. Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide. Inflammopharmacology, 2006, 14(3-4): 120-37.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Manicourt DH, Bevilacqua M, Righini V, Famaey JP, Devogelaer JP. Comparative effect of nimesulide and ibuprofen on the urinary levels of collagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metal loproteinases-3 and -13 in patients with flare-up of osteoarthritis. Drugs R D, 2005, 6(5): 261-271.</mixed-citation><mixed-citation xml:lang="en">Manicourt DH, Bevilacqua M, Righini V, Famaey JP, Devogelaer JP. Comparative effect of nimesulide and ibuprofen on the urinary levels of collagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metal loproteinases-3 and -13 in patients with flare-up of osteoarthritis. Drugs R D, 2005, 6(5): 261-271.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kullich WC, Niksic F, Klein G. Effect of nimesulide on metalloproteinases and matrix degradation in osteoarthritis: a pilot clinical study. Int J Clin Pract Suppl, 2002 Jul, 128: 24-29.</mixed-citation><mixed-citation xml:lang="en">Kullich WC, Niksic F, Klein G. Effect of nimesulide on metalloproteinases and matrix degradation in osteoarthritis: a pilot clinical study. Int J Clin Pract Suppl, 2002 Jul, 128: 24-29.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ding C. Do NSAIDs affect the progression of osteoarthritis? Inflammation, 2002 Jun, 26(3): 139-142.</mixed-citation><mixed-citation xml:lang="en">Ding C. Do NSAIDs affect the progression of osteoarthritis? Inflammation, 2002 Jun, 26(3): 139-142.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kriegel W, Korff KJ, Ehrlich JC, Lehnhardt K, Macciocchi A, Moresino C, PawlowskiC. Doubleblind study comparing the long-term efficacy of the COX-2 inhibitor nimesulide and naproxen in patients with osteoarthritis. Int J Clin Pract, 2001 Oct, 55(8): 510-514.</mixed-citation><mixed-citation xml:lang="en">Kriegel W, Korff KJ, Ehrlich JC, Lehnhardt K, Macciocchi A, Moresino C, PawlowskiC. Doubleblind study comparing the long-term efficacy of the COX-2 inhibitor nimesulide and naproxen in patients with osteoarthritis. Int J Clin Pract, 2001 Oct, 55(8): 510-514.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Herrera JA, González M. Comparative evaluation of the effectiveness and tolerability of nimesulide versus rofecoxib taken once a day in the treatment of patients with knee osteoarthritis. Am J Ther, 2003 Nov-Dec, 10(6): 468-472.</mixed-citation><mixed-citation xml:lang="en">Herrera JA, González M. Comparative evaluation of the effectiveness and tolerability of nimesulide versus rofecoxib taken once a day in the treatment of patients with knee osteoarthritis. Am J Ther, 2003 Nov-Dec, 10(6): 468-472.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Pohjolainen T, Jekunen A, Autio L, Vuorela H. Treatment of acute low back pain with the COX2-selective anti-inflammatory drug nimesulide: results of a randomized, double-blind comparative trial versus ibuprofen. Spine (Phila Pa 1976), 2000 Jun 15, 25(12): 1579-1585.</mixed-citation><mixed-citation xml:lang="en">Pohjolainen T, Jekunen A, Autio L, Vuorela H. Treatment of acute low back pain with the COX2-selective anti-inflammatory drug nimesulide: results of a randomized, double-blind comparative trial versus ibuprofen. Spine (Phila Pa 1976), 2000 Jun 15, 25(12): 1579-1585.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Чичасова Н.В. Проблема оценки эффективности и безопасности нестероидных противовоспалительных препаратов. Совpeменная ревматология, 2016, 2: 8388.</mixed-citation><mixed-citation xml:lang="en">Chichasova NV. The issue of evaluating the efficacy and safety of nonsteroidal anti-inflammatory drugs. Sovpemennaya Revmatologiya, 2016, 2: 83-88</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Traversa G, Bianchi C, Da Cas R, et al. Cohort study of hepatotoxity associated with nimesulide and other nonsteroidal anti-inflammatory drugs. BMJ, 2003 Jul 5, 327(7405): 18–22.</mixed-citation><mixed-citation xml:lang="en">Traversa G, Bianchi C, Da Cas R, et al. Cohort study of hepatotoxity associated with nimesulide and other nonsteroidal anti-inflammatory drugs. BMJ, 2003 Jul 5, 327(7405): 18–22.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Gulmez SE, Larrey D, Pageaux GP, et al. Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational casepopulation SALT study. Drug Saf, 2013 Feb, 36(2): 135–44. doi: 10.1007/s40264-012-0013-7.</mixed-citation><mixed-citation xml:lang="en">Gulmez SE, Larrey D, Pageaux GP, et al. Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational casepopulation SALT study. Drug Saf, 2013 Feb, 36(2): 135–44. doi: 10.1007/s40264-012-0013-7.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Каратеев А.Е. Российский опыт применения нимесулида: обзор клинических испытаний. Consilium medicum. 2011; 13(9):89-95;</mixed-citation><mixed-citation xml:lang="en">Karateev AE. Russian experience in using nimesulide: review of clinical trials. Consilium Medicum. 2011; 13 (9): 89-95;</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Каратеев А.Е. Алексеева Л.И., Братыгина Е.А., Аширова Т.Б. Оценка частоты развития побочных эффектов при длительном применении нимесулида в реальной клинической практике. РМЖ, 2009, 17(21): 1466–72.</mixed-citation><mixed-citation xml:lang="en">Karateev AE, Alekseeva LI, Bratygina EA, Ashirova TB. Evaluation of the incidence of side effects of nimesulide long-term use in real clinical practice. Breast Cancer, 2009, 17 (21): 1466–72.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Имаметдинова Г.Р., Чичасова Н.В. Нимесулид при лечении острой и хронической боли. Медицинский Совет, 2017, 11: 126-132.</mixed-citation><mixed-citation xml:lang="en">Imametdinova GR, Chichasova NV. Nimesulide in treatment of acute and chronic pain. Meditsinsky Sovet, 2017, 11: 126-132.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
